Pharmacist-assessed medication adherence and quality of life in patients with epilepsy.

ABSTRACT:

Background

Epilepsy affects approximately 65 million individuals globally, with medication adherence a critical determinant of seizure control and quality of life (QoL). Community pharmacists, with their accessibility and expertise, are well positioned to support adherence and patient education. However, little is known about the interplay between adherence, readiness for change, and QoL in patients with epilepsy (PWE) in Cyprus. This study is the first comprehensive investigation in Cyprus, addressing this evidence gap and highlighting opportunities for pharmacist-led interventions.

Methods

This cross-sectional study (Sep 2022 - Oct 2023) was conducted at Limassol General Hospital. Greek-speaking adult PWE (N = 85) were assessed via semi-structured telephone interviews usin

SUBMITTER: Petrides M 

PROVIDER: S-EPMC12451955 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature